Home ›
Entities
› academia
› Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
Research article (Drug Metabolism and Disposition, 2017) · cited 46× · AI/ML
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
Summary
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control is a scholarly article[1].
Key Facts
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control. Retrieved May 24, 2026, from https://4ort.xyz/entity/considerations-from-the-iq-induction-working-group-in-response-to-drug-drug-interaction-guidance-from-regulatory-agencie
MLA“Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/considerations-from-the-iq-induction-working-group-in-response-to-drug-drug-interaction-guidance-from-regulatory-agencie.
BibTeX@misc{4ortxyz_considerations-from-the-iq-induction-working-group-in-response-to-drug-drug-interaction-guidance-from-regulatory-agencie_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control}}, year = {2026}, url = {https://4ort.xyz/entity/considerations-from-the-iq-induction-working-group-in-response-to-drug-drug-interaction-guidance-from-regulatory-agencie}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control — https://4ort.xyz/entity/considerations-from-the-iq-induction-working-group-in-response-to-drug-drug-interaction-guidance-from-regulatory-agencie (retrieved 2026-05-24)
